1/ A 40-year-old man presents with Dyspnea and this finding on CTPA ⬇️. How do we treat?
WOAHHH hold your 🐎! Although the CT is black & white, the approach to pulmonary embolism (PE) is more nuanced
Let's talk about PE diagnosis - A @CardioNerds 🧵...
@PERTConsortium #PERT
2/ Let’s start with PE Epidemiology 🧮
👉3rd leading cause of CV mortality
👉Annual incidence worldwide is 1 in 1000
👉120 per 100,000 in US
👉PE diagnosis continues to 📈
ahajournals.org/doi/10.1161/CI…
3/ Let’s follow the 5️⃣ steps of PE management:
1️⃣Suspect PE
2️⃣Estimate Risk of PE
3️⃣Diagnose with imaging
4️⃣Risk Stratification
5️⃣Treatment
Shoutout to @AmitGoyalMD for this framework
4/ ⚠️Risk Factors⚠️
Strong (OR>10)
▶️Major trauma or surgery
▶️Spinal cord injury
▶️Hip/knee replacement
▶️Hip/leg fracture
Moderate (OR 2-9)
▶️Malignancy
▶️Peripartum
▶️Previous VTE
▶️Thrombophilia
Weak (OR <2)
▶️Immobility
▶️Obesity
▶️Varicose Veins
ahajournals.org/doi/full/10.11…
5/ Common symptoms of PE:
▶️Fatigue
▶️Dyspnea
▶️Chest Pain
▶️Syncope/Presyncope
▶️Cough
▶️Diaphoresis
▶️Fever
▶️Hemoptysis
The symptoms are quite nonspecific so how do we make the diagnosis❓
6/ Diagnosis
⭐️if “clinical gestalt” <15%, the PERC rule can be used to ❌ PE
In the PROPER trial, PERC was non-inferior & required 10% fewer imaging studies vs standard care
jamanetwork.com/journals/jama/…
⭐️if “clinical gestalt” >15% or PERC positive....
7/ Wells score (≤4) or Revised Geneva score (≤10)
➕
D-Dimer below threshold
🟰
❌ PE (sens 98-99%, spec 37-40%)
jamanetwork.com/journals/jama/…
8/ If:
▶️D-dimer is above the threshold
▶️Clinical gestalt is high (>40%)
▶️Wells score >6
▶️Revised geneva score > 10
Next step: imaging 🩻
👀 this Dx strategy flow chart from Freund et al.
jamanetwork.com/journals/jama/…
9/ Main imaging modalities:
👉CTPA
▶️evidence of filling defect ➡️ sensitivity of 94% for PE
▶️can look for other pathology
👉V/Q scan
▶️not as available
▶️lower sensitivity for PE (56-98%)
▶️can't ID other pathology
10/ Now that we clinched the Dx, let’s risk stratify
▶️sPESI, RV:LV ratio on imaging, Biomarkers
▶️Out with massive/submassive. In with high, intermediate, and low risk per the AHA 2019 consensus statement
▶️ESC further stratifies to intermediate-high & intermediate-low risk
11/
⚠️High Risk
▶️New systolic BP <90 mmHg, ≥40 mmHg ⬇️ for ≥15 min
▶️Pressors
▶️Cardiac arrest
⚠️Intermediate ⬆️-risk
▶️sPESI ≥1
▶️RV/LV ratio >0.9 &⬆️biomarkers
⚠️Intermediate ⬇️-risk
▶️sPESI ≥1
▶️RV/LV ratio >0.9 OR ⬆️biomarkers
⚠️Low Risk
▶️lacks criteria for⬆️risk
12/
🛑High Risk
5% of PE
~30% ☠️
🛑Intermediate Risk
35-55% of PE
2-3% 30d ☠️ with up to 15% at 90d when treated with AC 💊 alone
🛑Low Risk
40-60% of PE
30d ☠️ = 1%
13/ How do we treat these patients❓
Stay tuned for part 2️⃣ as we venture into the 🌎 of Rx and escalation of care therapies.
Major 🙏 to @dinubalanescu for his guidance and @AmitGoyalMD @TDonisan and @Gurleen_Kaur96 for reviewing!!
Until then 👋
#CardioTwitter #ACCMedStudent
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.